Adiponectin has antidiabetic properties, and patients with obesity, diabetes, and insulin
resistance have low plasma adiponectin levels. However, although kidney disease is …

Adiponectin, a novel adipose-derived adipocytokine, has beneficial effects not only on
improvement of insulin sensitivity but also on mitigation of vascular damage. To evaluate …

Patients with end-stage renal disease (ESRD) show an inverse association between body
mass index and risk of death from cardiovascular disease. Paradoxical epidemiology may …

Abstract Background/Aim: Adiponectin, an adipocyte-derived protein, has been shown to
exert antidiabetic, anti-inflammatory, and antiatherosclerotic effects. Although recent reports …

Adiponectin is secreted specifically by adipose tissue. It was reported that the serum
adiponectin level was markedly increased in patients with end-stage renal disease and was …

Background Adiponectin plasma levels in chronic kidney disease (CKD) are two to three
times higher than in individuals with normal kidney function. Despite adiponectin's anti …

BACKGROUND: Adiponectin, a protein secreted exclusively by adipocytes, is presumed to
be involved in the pathogenesis of atherosclerosis and insulin resistance. An elevated …

Adiponectin in renal disease: Relationship to phenotype and genetic variation in the gene
encoding adiponectin. Background The prevalence of cardiovascular disease (CVD) and …

Background. Despite the favourable effects of adiponectin on the vasculature and insulin
resistance (IR), levels are increased in patients with end-stage kidney disease (ESKD), in …

Objective: To investigate changes of adiponectin and its receptors (Adipo R) in rats following
chronic renal failure. Methods: Male SD rats were randomly divided into two groups: control …